Literature DB >> 2260623

Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.

G Abdel-Aziz1, G Lebeau, P Y Rescan, B Clément, M Rissel, Y Deugnier, J P Campion, A Guillouzo.   

Abstract

The reversibility of hepatic fibrosis was investigated in an experimental model of extrahepatic cholestasis in the rat after common bile duct ligation for 2 weeks, followed by bilioduodenal anastomosis for 3 weeks. Bile duct ligation resulted in a transitory marked elevation in the serum concentration of 5'-nucleotidase, alkaline phosphatase, and bilirubin during the first 3 days. Then these levels decreased to threefold, twofold, and 100-fold the normal values, respectively, during the following 4 weeks. Histologic examination of the liver disclosed extensive bile duct proliferation and the formation of periportal fibrosis, with only slight inflammation and necrosis. The distribution of the major components of the hepatic extracellular matrix was analyzed 2 weeks after bile duct ligation, using the indirect immunoperoxidase method. Fibrous septa were found to be strongly stained for collagens I, pro-III, III and IV, fibronectin, and laminin. The most intense staining was found in enlarged periportal areas, collagen IV and laminin being particularly abundant around newly formed bile ducts. These changes paralleled high steady-state levels of alpha 1(I) and alpha 1(IV) collagen and B2 chain laminin mRNAs. Relief of the obstruction for 2 weeks resulted in a shift in the serum concentration of 5'-nucleotidase, alkaline phosphatase, and bilirubin toward normal values. A dramatic resorption of bile duct proliferations and periportal fibrosis were observed. Three weeks after bile duct repermeabilization, immunohistochemical study showed that the pattern of distribution of extracellular matrix components was almost normal, except for collagen IV, which remained abundant in the sinusoids when compared with the normal liver. In parallel, the steady-state B2-chain laminin mRNA level became lower than in cholestatic livers, whereas alpha 1(I) and alpha 1(IV) mRNAs were almost undetectable. These results show that hepatic fibrosis induced by experimental extrahepatic cholestasis in rat disappears in less than 3 weeks after relief of bile duct obstruction, suggesting that an active degradation of matrix protein occurs, except for collagen IV in the sinusoid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2260623      PMCID: PMC1877723     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Amino acid sequence of the non-collagenous globular domain (NC1) of the alpha 1(IV) chain of basement membrane collagen as derived from complementary DNA.

Authors:  I Oberbäumer; M Laurent; U Schwarz; Y Sakurai; Y Yamada; G Vogeli; T Voss; B Siebold; R W Glanville; K Kühn
Journal:  Eur J Biochem       Date:  1985-03-01

Review 2.  The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CCl4-induced cirrhosis.

Authors:  A Martinez-Hernandez
Journal:  Lab Invest       Date:  1985-08       Impact factor: 5.662

3.  A procedure for light and electron microscopic intracellular immunolocalization of collagen and fibronectin in rat liver.

Authors:  B Clement; M Rissel; S Peyrol; Y Mazurier; J A Grimaud; A Guillouzo
Journal:  J Histochem Cytochem       Date:  1985-05       Impact factor: 2.479

4.  Cellular origin of collagen and fibronectin in the liver.

Authors:  B Clément; H Emonard; M Rissel; M Druguet; J A Grimaud; D Herbage; M Bourel; A Guillouzo
Journal:  Cell Mol Biol       Date:  1984       Impact factor: 1.770

5.  Hepatic collagenase activity during carbon tetrachloride induced fibrosis.

Authors:  W J Lindblad; G C Fuller
Journal:  Fundam Appl Toxicol       Date:  1983 Jan-Feb

6.  Collagen formation by the hepatocyte in primary monolayer culture and in vivo.

Authors:  R F Diegelmann; P S Guzelian; R Gay; S Gay
Journal:  Science       Date:  1983-03-18       Impact factor: 47.728

7.  A scanning and transmission electron microscopic study of experimental extrahepatic cholestasis in the rat.

Authors:  F Carpino; E Gaudio; G Marinozzi; M Melis; P M Motta
Journal:  J Submicrosc Cytol       Date:  1981-10

8.  Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis.

Authors:  K Maruyama; L Feinman; Z Fainsilber; M Nakano; I Okazaki; C S Lieber
Journal:  Life Sci       Date:  1982-04-19       Impact factor: 5.037

9.  Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat.

Authors:  J Kountouras; B H Billing; P J Scheuer
Journal:  Br J Exp Pathol       Date:  1984-06

10.  Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis.

Authors:  S H Morcos; M T Khayyal; M M Mansour; S Saleh; E A Ishak; N I Girgis; M A Dunn
Journal:  Am J Trop Med Hyg       Date:  1985-03       Impact factor: 2.345

View more
  31 in total

Review 1.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 2.  Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered.

Authors:  Valeer J Desmet
Journal:  Virchows Arch       Date:  2011-02-02       Impact factor: 4.064

3.  Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE.

Authors:  Makoto Nakamuta; Kazuhiro Kotoh; Munechika Enjoji; Hajime Nawata
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

4.  Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.

Authors:  Biju Parekkadan; Daan van Poll; Zaki Megeed; Naoya Kobayashi; Arno W Tilles; François Berthiaume; Martin L Yarmush
Journal:  Biochem Biophys Res Commun       Date:  2007-05-30       Impact factor: 3.575

5.  Enhanced matrix degradation after withdrawal of TGF-beta1 triggers hepatocytes from apoptosis to proliferation and regeneration.

Authors:  E Arendt; U Ueberham; R Bittner; R Gebhardt; E Ueberham
Journal:  Cell Prolif       Date:  2005-10       Impact factor: 6.831

6.  Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors.

Authors:  R Issa; E Williams; N Trim; T Kendall; M J Arthur; J Reichen; R C Benyon; J P Iredale
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

7.  Monitoring the Progression of Chronic Liver Damage in Rats Using [18F]PBR06.

Authors:  Shuo Huang; Chao Li; Jun Guo; Linlin Zhang; Shuqi Wu; Hui Wang; Sheng Liang
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

8.  Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.

Authors:  Yury Popov; Deanna Y Sverdlov; K Ramakrishnan Bhaskar; Anisha K Sharma; Gunda Millonig; Eleonora Patsenker; Stephan Krahenbuhl; Lukas Krahenbuhl; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-01-07       Impact factor: 4.052

9.  Visualising liver fibrosis by phase-contrast X-ray imaging in common bile duct ligated mice.

Authors:  Xi Zhang; Xin-Rong Yang; Yu Chen; Hai-Qing Li; Rui-Min Li; Qing-Xi Yuan; Pei-Ping Zhu; Wan-Xia Huang; Wei-Jun Peng
Journal:  Eur Radiol       Date:  2012-08-19       Impact factor: 5.315

10.  Inhibitory effects of rapamycin on the different stages of hepatic fibrosis.

Authors:  Yun Jeung Kim; Eaum Seok Lee; Seok Hyun Kim; Heon Young Lee; Seung Moo Noh; Dae Young Kang; Byung Seok Lee
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.